• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肺结核患者手术准备期间的止血系统]

[The hemostatic system in patients with pulmonary tuberculosis during their preparation for surgery].

作者信息

Makinskiĭ A I, Ivan'ko T P, Makarova V V, Polozov A I

出版信息

Probl Tuberk. 1991(8):39-42.

PMID:1758856
Abstract

The basic mechanisms responsible for equilibrium impairment in the hemostatic system in pulmonary tuberculosis patients are reduced activity of antithrombin III and disturbances of platelet functional capacities. These changes were proved to reflect the course of intravascular hemocoagulation whose degree of manifestation is related directly to the extent of specific lesions in the lungs and intoxication phenomena. The process of intravascular hemocoagulation in tuberculosis patients runs in the presence of an increased concentration of plasma fibronectin , while major surgery performed in patients with fibrous-cavernous processes leads to its reduced level. It is pathogenetically proved to use antithrombin III concentrate preparations with anti- and dysaggregatory properties, fibronectin preparations, trasylol or its analogs during complex preoperative preparation of patients.

摘要

肺结核患者止血系统平衡受损的基本机制是抗凝血酶III活性降低和血小板功能能力紊乱。这些变化被证明反映了血管内凝血过程,其表现程度与肺部特异性病变的范围和中毒现象直接相关。肺结核患者的血管内凝血过程在血浆纤连蛋白浓度升高的情况下发生,而在纤维空洞型肺结核患者进行大手术时会导致其水平降低。从发病机制上证明,在患者的复杂术前准备过程中使用具有抗聚集和抗解聚特性的抗凝血酶III浓缩制剂、纤连蛋白制剂、抑肽酶或其类似物。

相似文献

1
[The hemostatic system in patients with pulmonary tuberculosis during their preparation for surgery].[肺结核患者手术准备期间的止血系统]
Probl Tuberk. 1991(8):39-42.
2
[The use of a concentrate of antithrombin III and disaggregants in the preoperative preparation of patients with pulmonary tuberculosis].[抗凝血酶III浓缩物和抗聚集剂在肺结核患者术前准备中的应用]
Vrach Delo. 1990 May(5):73-4.
3
[The correction of disorders in the blood coagulating system during the surgical treatment of patients with pulmonary tuberculosis].[肺结核患者外科治疗期间血液凝固系统紊乱的纠正]
Vrach Delo. 1991 Sep(9):54-7.
4
[Arteriovenous differences in the state of the hemostasis system of patients with pulmonary tuberculosis].[肺结核患者止血系统状态的动静脉差异]
Probl Tuberk. 1992(1-2):10-3.
5
[Hemostasis disorders in patients with pulmonary tuberculosis].[肺结核患者的止血障碍]
Probl Tuberk. 1995(1):33-5.
6
[Pathogenesis and prevention of coagulopathies in patients during surgery for fibrous-cavernous pulmonary tuberculosis].[纤维空洞型肺结核患者手术期间凝血障碍的发病机制与预防]
Probl Tuberk. 1987(9):51-5.
7
[Thrombohemorrhagic and acute circulatory complications of the surgical treatment of tuberculosis].
Probl Tuberk. 1990(6):49-52.
8
[Blood coagulation function in pulmonary tuberculosis patients at the stages of surgical treatment].[肺结核患者外科治疗各阶段的血液凝固功能]
Probl Tuberk. 1989(12):41-6.
9
[Coagulation and anticoagulation systems of blood in pateints with pulmonary tuberculosis in connection with surgery and anestesia].[肺结核患者血液的凝血与抗凝系统与手术及麻醉的关系]
Probl Tuberk. 1974;52(6):48-52.
10
Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.纤维蛋白溶解与凝血抑制的病理生理学及临床方面。特别针对口服避孕药的女性和特定血栓易患人群的实验与临床研究。
Dan Med Bull. 1988 Feb;35(1):1-33.